Time & Date: 3 September, 08:45 – 09:45 CEST
Moderator: P. Scanlon UK
Speakers & Presentations:
P. Scanlon UK
08:45 Welcome
J. Huemer UK
08:47 Risk of cardiovascular events requiring hospital admission following retinal arterial occlusion and transient monocular visual loss
S.C. Millas SPAIN
08:52 Analysis of the certification for capturing and reading programme and the diabetic retinopathy screening programme of The Governing Board of Castilla Y León (Spain)
H. Shahzad UK
08:57 Patients’ Perceptions of Visual Impairment Associated with Smoking: A Cross-sectional Study of a United Kingdom Tertiary Eye Centre
P. Scanlon UK
09:02 A real-world study of the prevalence and progression of diabetic macular ischemia in patients with diabetic retinopathy: EYE DMI
J. Garweg SWITZERLAND
09:07 Intraocular apolipoprotein concentrations and severity of diabetic retinopathy in type 2 diabetes
O. Altunel TURKEY
09:12 Comparison of aflibercept and dexamethasone implant treatment in patients with diabetic macular edema with and without hyperreflective foci
M. Popovic CANANDA
09:17 Intravitreal dexamethasone and triamcinolone acetonide compared to anti-vascular endothelial growth factor treatment for diabetic macular edema: a meta-analysis
R. Castro Florez SPAIN
09:22 Study of efficacy and safety of early panretinal photocoagulation in patients with severe non-proliferative diabetic retinopathy
All Faculty
09:27 Discussion
